These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 7410118)

  • 1. Liver membrane antigen-targets of humoral and cell mediated immunity in chronic active hepatitis.
    Manns M; Kawakami H; Meyer zum Büschenfelde KH
    Hiroshima J Med Sci; 1980 Jun; 29(2):41-7. PubMed ID: 7410118
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunologic liver injury: the role of hepatitis B viral antigens and liver membrane antigens as targets.
    Meyer zum Büschenfelde KH; Hütteroth TH; Arnold W; Hopf U
    Prog Liver Dis; 1979; 6():407-24. PubMed ID: 396565
    [No Abstract]   [Full Text] [Related]  

  • 3. Proceedings: Cell-mediated immunity to hepatitis B antigen in antigen-negative active chronic hepatitis.
    Reed WD; Lee WM; Eddleston AL; Mitchell CG; Zuckerman AJ; Williams R
    Gut; 1974 Apr; 15(4):341-2. PubMed ID: 4834574
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cellular immunity in chronic hepatitis and cirrhosis of the liver in response to Australia antigen].
    Tareev EM; Kantorovich RA; Traianova TG; Lenchik VI; Mazharov MK
    Sov Med; 1973 May; 36(5):3-6. PubMed ID: 4768343
    [No Abstract]   [Full Text] [Related]  

  • 5. [Indicators of cellular immunity in patients with chronic active hepatitis].
    Severov MV; Semendiaeva ME; Traianova TG; Mukhin AS
    Sov Med; 1975 May; (5):107-12. PubMed ID: 1145293
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cellular immune reactions against hepatitis associated antigen (HAA) and homologous liver specific antigen in acute HAA positive hepatitis].
    Knolle J; Meyer zum Büschenfelde ; Friedrichs N; Bolte JP
    Verh Dtsch Ges Inn Med; 1973; 79():639-41. PubMed ID: 4790318
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immunopathology of chronic liver diseases].
    Meyer zum Büschenfelde KH
    Verh Dtsch Ges Pathol; 1995; 79():186-97. PubMed ID: 8600684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Demonstration of cellular immune phenomenons in inflammatory liver disease].
    Warnatz H; Scheiffarth F; Rüters J; Baenkler H
    Verh Dtsch Ges Inn Med; 1972; 78():919-22. PubMed ID: 4665780
    [No Abstract]   [Full Text] [Related]  

  • 9. [Chronic active hepatitis as a systemic disease].
    Aprosina ZG; Tareev EM; Bezprozvannyĭ BK; Potekaeva MA; Trainanova TG
    Ter Arkh; 1975; 47(4):127-38. PubMed ID: 1145473
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatic expression of the woodchuck hepatitis virus X-antigen during acute and chronic infection and detection of a woodchuck hepatitis virus X-antigen antibody response.
    Jacob JR; Ascenzi MA; Roneker CA; Toshkov IA; Cote PJ; Gerin JL; Tennant BC
    Hepatology; 1997 Dec; 26(6):1607-15. PubMed ID: 9398005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the pathogenesis of experimental chronic active hepatitis in rabbits. I. Induction of the disease and protective effect of allogeneic liver specific proteins.
    Meyer zum Büschenfelde KH; Hopf U
    Br J Exp Pathol; 1974 Oct; 55(5):498-508. PubMed ID: 4451636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immune response induced by hepatitis B virus principal antigens.
    Huang CF; Lin SS; Ho YC; Chen FL; Yang CC
    Cell Mol Immunol; 2006 Apr; 3(2):97-106. PubMed ID: 16696896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver-specific protein: more questions than answers.
    Dienstag JL; Isselbacher KJ
    N Engl J Med; 1978 Jul; 299(1):40-2. PubMed ID: 78441
    [No Abstract]   [Full Text] [Related]  

  • 14. Specificity of humoral and cellular immune response against recombinant particles of nucleocapsid protein of human hepatitis B virus in rabbits.
    Isaguliants MG; Kadoshnikov YP; Kalinina TI; Smirnov VD; Wahren B
    Biochemistry (Mosc); 1998 May; 63(5):551-8. PubMed ID: 9632891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Incidence of Australia antigen in patients with chronic hepatitis].
    Tkaczewski W; Niedzielska H; Krawczyńska B; Skatulska-Surmacka T; Tomczyk-Budzińska H
    Pol Tyg Lek; 1972 Jul; 27(28):1075-7. PubMed ID: 5069438
    [No Abstract]   [Full Text] [Related]  

  • 16. Immune responses to liver-specific lipoprotein and liver membrane antigen: a tabular interpretative review.
    Frazer IH; Mackay IR
    J Clin Lab Immunol; 1984 Aug; 14(4):165-7. PubMed ID: 6492122
    [No Abstract]   [Full Text] [Related]  

  • 17. Antibody-dependent cell-mediated cytotoxicity and hepatocyte membrane-fixed IgG in chronic active hepatitis.
    Nonomura A; Shintani T; Ohta G
    Gastroenterology; 1978 Mar; 74(3):640-1. PubMed ID: 631498
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cellular immunity against hepatitis B antigen in hepatopathies].
    Martínez-Vázquez J; Guardia J; Vilaseca J; Pedreira J; Bacardl R; Tornos J
    Rev Clin Esp; 1974 Dec; 135(6):545-51. PubMed ID: 4460097
    [No Abstract]   [Full Text] [Related]  

  • 19. [Liver and cellular immunity].
    Ito K; Nakano H; Sano M
    Nihon Rinsho; 1978 May; Suppl():2200-1. PubMed ID: 691695
    [No Abstract]   [Full Text] [Related]  

  • 20. A fusion product of the complete Borrelia burgdorferi outer surface protein A (OspA) and the hepatitis B virus capsid protein is highly immunogenic and induces protective immunity similar to that seen with an effective lipidated OspA vaccine formula.
    Nassal M; Skamel C; Kratz PA; Wallich R; Stehle T; Simon MM
    Eur J Immunol; 2005 Feb; 35(2):655-65. PubMed ID: 15668917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.